nodes	percent_of_prediction	percent_of_DWPC	metapath
Trihexyphenidyl—Blindness—Tamoxifen—pancreatic cancer	0.00791	0.0687	CcSEcCtD
Trihexyphenidyl—Blindness—Sunitinib—pancreatic cancer	0.00678	0.0588	CcSEcCtD
Trihexyphenidyl—Dry skin—Erlotinib—pancreatic cancer	0.00288	0.025	CcSEcCtD
Trihexyphenidyl—Blindness—Epirubicin—pancreatic cancer	0.0026	0.0226	CcSEcCtD
Trihexyphenidyl—Euphoric mood—Fluorouracil—pancreatic cancer	0.00254	0.0221	CcSEcCtD
Trihexyphenidyl—Dry skin—Sunitinib—pancreatic cancer	0.0025	0.0217	CcSEcCtD
Trihexyphenidyl—Weight decreased—Tamoxifen—pancreatic cancer	0.00249	0.0216	CcSEcCtD
Trihexyphenidyl—Weight decreased—Erlotinib—pancreatic cancer	0.00246	0.0214	CcSEcCtD
Trihexyphenidyl—Blindness—Doxorubicin—pancreatic cancer	0.00241	0.0209	CcSEcCtD
Trihexyphenidyl—Weight decreased—Sunitinib—pancreatic cancer	0.00213	0.0185	CcSEcCtD
Trihexyphenidyl—Dry skin—Fluorouracil—pancreatic cancer	0.00197	0.0171	CcSEcCtD
Trihexyphenidyl—Weight decreased—Irinotecan—pancreatic cancer	0.00175	0.0152	CcSEcCtD
Trihexyphenidyl—Dry skin—Docetaxel—pancreatic cancer	0.00142	0.0123	CcSEcCtD
Trihexyphenidyl—Constipation—Tamoxifen—pancreatic cancer	0.00134	0.0116	CcSEcCtD
Trihexyphenidyl—Constipation—Erlotinib—pancreatic cancer	0.00132	0.0115	CcSEcCtD
Trihexyphenidyl—Vision blurred—Fluorouracil—pancreatic cancer	0.00122	0.0106	CcSEcCtD
Trihexyphenidyl—Weight decreased—Docetaxel—pancreatic cancer	0.00121	0.0105	CcSEcCtD
Trihexyphenidyl—Constipation—Sunitinib—pancreatic cancer	0.00115	0.00994	CcSEcCtD
Trihexyphenidyl—Asthenia—Tamoxifen—pancreatic cancer	0.00112	0.00973	CcSEcCtD
Trihexyphenidyl—Confusional state—Irinotecan—pancreatic cancer	0.00111	0.00965	CcSEcCtD
Trihexyphenidyl—Asthenia—Erlotinib—pancreatic cancer	0.00111	0.00963	CcSEcCtD
Trihexyphenidyl—Confusional state—Fluorouracil—pancreatic cancer	0.00107	0.00924	CcSEcCtD
Trihexyphenidyl—Dizziness—Tamoxifen—pancreatic cancer	0.00103	0.00897	CcSEcCtD
Trihexyphenidyl—Tachycardia—Fluorouracil—pancreatic cancer	0.00103	0.00895	CcSEcCtD
Trihexyphenidyl—Dizziness—Erlotinib—pancreatic cancer	0.00102	0.00888	CcSEcCtD
Trihexyphenidyl—Vomiting—Tamoxifen—pancreatic cancer	0.000994	0.00863	CcSEcCtD
Trihexyphenidyl—Rash—Tamoxifen—pancreatic cancer	0.000986	0.00855	CcSEcCtD
Trihexyphenidyl—Dermatitis—Tamoxifen—pancreatic cancer	0.000985	0.00855	CcSEcCtD
Trihexyphenidyl—Vomiting—Erlotinib—pancreatic cancer	0.000984	0.00853	CcSEcCtD
Trihexyphenidyl—Somnolence—Irinotecan—pancreatic cancer	0.000981	0.00851	CcSEcCtD
Trihexyphenidyl—Headache—Tamoxifen—pancreatic cancer	0.000979	0.0085	CcSEcCtD
Trihexyphenidyl—Rash—Erlotinib—pancreatic cancer	0.000975	0.00846	CcSEcCtD
Trihexyphenidyl—Dermatitis—Erlotinib—pancreatic cancer	0.000974	0.00846	CcSEcCtD
Trihexyphenidyl—Headache—Erlotinib—pancreatic cancer	0.000969	0.00841	CcSEcCtD
Trihexyphenidyl—Asthenia—Sunitinib—pancreatic cancer	0.000961	0.00834	CcSEcCtD
Trihexyphenidyl—Dry skin—Epirubicin—pancreatic cancer	0.000959	0.00832	CcSEcCtD
Trihexyphenidyl—Somnolence—Gemcitabine—pancreatic cancer	0.000955	0.00829	CcSEcCtD
Trihexyphenidyl—Constipation—Irinotecan—pancreatic cancer	0.000943	0.00818	CcSEcCtD
Trihexyphenidyl—Somnolence—Fluorouracil—pancreatic cancer	0.000939	0.00815	CcSEcCtD
Trihexyphenidyl—Nausea—Tamoxifen—pancreatic cancer	0.000929	0.00806	CcSEcCtD
Trihexyphenidyl—Constipation—Gemcitabine—pancreatic cancer	0.000919	0.00797	CcSEcCtD
Trihexyphenidyl—Nausea—Erlotinib—pancreatic cancer	0.000919	0.00797	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Irinotecan—pancreatic cancer	0.000909	0.00789	CcSEcCtD
Trihexyphenidyl—Dry skin—Doxorubicin—pancreatic cancer	0.000887	0.0077	CcSEcCtD
Trihexyphenidyl—Dizziness—Sunitinib—pancreatic cancer	0.000885	0.00768	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000885	0.00768	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000871	0.00755	CcSEcCtD
Trihexyphenidyl—Vomiting—Sunitinib—pancreatic cancer	0.000851	0.00739	CcSEcCtD
Trihexyphenidyl—Rash—Sunitinib—pancreatic cancer	0.000844	0.00733	CcSEcCtD
Trihexyphenidyl—Dermatitis—Sunitinib—pancreatic cancer	0.000844	0.00732	CcSEcCtD
Trihexyphenidyl—Headache—Sunitinib—pancreatic cancer	0.000839	0.00728	CcSEcCtD
Trihexyphenidyl—Weight decreased—Epirubicin—pancreatic cancer	0.000818	0.0071	CcSEcCtD
Trihexyphenidyl—Drowsiness—Epirubicin—pancreatic cancer	0.000806	0.007	CcSEcCtD
Trihexyphenidyl—Nausea—Sunitinib—pancreatic cancer	0.000795	0.0069	CcSEcCtD
Trihexyphenidyl—Asthenia—Irinotecan—pancreatic cancer	0.000791	0.00687	CcSEcCtD
Trihexyphenidyl—Asthenia—Gemcitabine—pancreatic cancer	0.000771	0.00669	CcSEcCtD
Trihexyphenidyl—Confusional state—Docetaxel—pancreatic cancer	0.000769	0.00667	CcSEcCtD
Trihexyphenidyl—Weight decreased—Doxorubicin—pancreatic cancer	0.000757	0.00657	CcSEcCtD
Trihexyphenidyl—Drowsiness—Doxorubicin—pancreatic cancer	0.000746	0.00647	CcSEcCtD
Trihexyphenidyl—Tachycardia—Docetaxel—pancreatic cancer	0.000744	0.00646	CcSEcCtD
Trihexyphenidyl—Dizziness—Irinotecan—pancreatic cancer	0.000729	0.00633	CcSEcCtD
Trihexyphenidyl—Vomiting—Irinotecan—pancreatic cancer	0.000701	0.00609	CcSEcCtD
Trihexyphenidyl—Dizziness—Fluorouracil—pancreatic cancer	0.000699	0.00606	CcSEcCtD
Trihexyphenidyl—Rash—Irinotecan—pancreatic cancer	0.000695	0.00603	CcSEcCtD
Trihexyphenidyl—Dermatitis—Irinotecan—pancreatic cancer	0.000695	0.00603	CcSEcCtD
Trihexyphenidyl—Headache—Irinotecan—pancreatic cancer	0.000691	0.006	CcSEcCtD
Trihexyphenidyl—Vomiting—Gemcitabine—pancreatic cancer	0.000683	0.00593	CcSEcCtD
Trihexyphenidyl—Somnolence—Docetaxel—pancreatic cancer	0.000678	0.00588	CcSEcCtD
Trihexyphenidyl—Rash—Gemcitabine—pancreatic cancer	0.000677	0.00588	CcSEcCtD
Trihexyphenidyl—Dermatitis—Gemcitabine—pancreatic cancer	0.000677	0.00587	CcSEcCtD
Trihexyphenidyl—Headache—Gemcitabine—pancreatic cancer	0.000673	0.00584	CcSEcCtD
Trihexyphenidyl—Vomiting—Fluorouracil—pancreatic cancer	0.000672	0.00583	CcSEcCtD
Trihexyphenidyl—Rash—Fluorouracil—pancreatic cancer	0.000666	0.00578	CcSEcCtD
Trihexyphenidyl—Dermatitis—Fluorouracil—pancreatic cancer	0.000665	0.00577	CcSEcCtD
Trihexyphenidyl—Headache—Fluorouracil—pancreatic cancer	0.000662	0.00574	CcSEcCtD
Trihexyphenidyl—Nausea—Irinotecan—pancreatic cancer	0.000655	0.00569	CcSEcCtD
Trihexyphenidyl—Constipation—Docetaxel—pancreatic cancer	0.000652	0.00566	CcSEcCtD
Trihexyphenidyl—Nausea—Gemcitabine—pancreatic cancer	0.000638	0.00554	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Docetaxel—pancreatic cancer	0.000628	0.00545	CcSEcCtD
Trihexyphenidyl—Nausea—Fluorouracil—pancreatic cancer	0.000627	0.00545	CcSEcCtD
Trihexyphenidyl—Tension—Epirubicin—pancreatic cancer	0.000618	0.00537	CcSEcCtD
Trihexyphenidyl—Nervousness—Epirubicin—pancreatic cancer	0.000612	0.00531	CcSEcCtD
Trihexyphenidyl—Vision blurred—Epirubicin—pancreatic cancer	0.000594	0.00515	CcSEcCtD
Trihexyphenidyl—Agitation—Epirubicin—pancreatic cancer	0.000579	0.00503	CcSEcCtD
Trihexyphenidyl—Tension—Doxorubicin—pancreatic cancer	0.000572	0.00496	CcSEcCtD
Trihexyphenidyl—Nervousness—Doxorubicin—pancreatic cancer	0.000566	0.00491	CcSEcCtD
Trihexyphenidyl—Vision blurred—Doxorubicin—pancreatic cancer	0.00055	0.00477	CcSEcCtD
Trihexyphenidyl—Asthenia—Docetaxel—pancreatic cancer	0.000547	0.00475	CcSEcCtD
Trihexyphenidyl—Agitation—Doxorubicin—pancreatic cancer	0.000536	0.00465	CcSEcCtD
Trihexyphenidyl—Confusional state—Epirubicin—pancreatic cancer	0.000519	0.0045	CcSEcCtD
Trihexyphenidyl—Dizziness—Docetaxel—pancreatic cancer	0.000504	0.00438	CcSEcCtD
Trihexyphenidyl—Tachycardia—Epirubicin—pancreatic cancer	0.000502	0.00436	CcSEcCtD
Trihexyphenidyl—Vomiting—Docetaxel—pancreatic cancer	0.000485	0.00421	CcSEcCtD
Trihexyphenidyl—Rash—Docetaxel—pancreatic cancer	0.000481	0.00417	CcSEcCtD
Trihexyphenidyl—Dermatitis—Docetaxel—pancreatic cancer	0.00048	0.00417	CcSEcCtD
Trihexyphenidyl—Confusional state—Doxorubicin—pancreatic cancer	0.00048	0.00416	CcSEcCtD
Trihexyphenidyl—Headache—Docetaxel—pancreatic cancer	0.000478	0.00414	CcSEcCtD
Trihexyphenidyl—Tachycardia—Doxorubicin—pancreatic cancer	0.000464	0.00403	CcSEcCtD
Trihexyphenidyl—Somnolence—Epirubicin—pancreatic cancer	0.000457	0.00397	CcSEcCtD
Trihexyphenidyl—Nausea—Docetaxel—pancreatic cancer	0.000453	0.00393	CcSEcCtD
Trihexyphenidyl—Constipation—Epirubicin—pancreatic cancer	0.00044	0.00382	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Epirubicin—pancreatic cancer	0.000424	0.00368	CcSEcCtD
Trihexyphenidyl—Somnolence—Doxorubicin—pancreatic cancer	0.000423	0.00367	CcSEcCtD
Trihexyphenidyl—Constipation—Doxorubicin—pancreatic cancer	0.000407	0.00353	CcSEcCtD
Trihexyphenidyl—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000392	0.0034	CcSEcCtD
Trihexyphenidyl—Asthenia—Epirubicin—pancreatic cancer	0.000369	0.0032	CcSEcCtD
Trihexyphenidyl—Asthenia—Doxorubicin—pancreatic cancer	0.000341	0.00296	CcSEcCtD
Trihexyphenidyl—Dizziness—Epirubicin—pancreatic cancer	0.00034	0.00295	CcSEcCtD
Trihexyphenidyl—Vomiting—Epirubicin—pancreatic cancer	0.000327	0.00284	CcSEcCtD
Trihexyphenidyl—Rash—Epirubicin—pancreatic cancer	0.000324	0.00281	CcSEcCtD
Trihexyphenidyl—Dermatitis—Epirubicin—pancreatic cancer	0.000324	0.00281	CcSEcCtD
Trihexyphenidyl—Headache—Epirubicin—pancreatic cancer	0.000322	0.0028	CcSEcCtD
Trihexyphenidyl—Dizziness—Doxorubicin—pancreatic cancer	0.000315	0.00273	CcSEcCtD
Trihexyphenidyl—Nausea—Epirubicin—pancreatic cancer	0.000305	0.00265	CcSEcCtD
Trihexyphenidyl—Vomiting—Doxorubicin—pancreatic cancer	0.000303	0.00263	CcSEcCtD
Trihexyphenidyl—Rash—Doxorubicin—pancreatic cancer	0.0003	0.0026	CcSEcCtD
Trihexyphenidyl—Dermatitis—Doxorubicin—pancreatic cancer	0.0003	0.0026	CcSEcCtD
Trihexyphenidyl—Headache—Doxorubicin—pancreatic cancer	0.000298	0.00259	CcSEcCtD
Trihexyphenidyl—Nausea—Doxorubicin—pancreatic cancer	0.000283	0.00245	CcSEcCtD
Trihexyphenidyl—CHRM1—Signaling Pathways—SST—pancreatic cancer	0.000227	0.000257	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—STK11—pancreatic cancer	0.000227	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SST—pancreatic cancer	0.000226	0.000256	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SST—pancreatic cancer	0.000224	0.000253	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000224	0.000253	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000223	0.000252	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—JAG1—pancreatic cancer	0.000222	0.000251	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—CXCL8—pancreatic cancer	0.000222	0.000251	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—JAG1—pancreatic cancer	0.000222	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000221	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000221	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000221	0.00025	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOTCH3—pancreatic cancer	0.000221	0.000249	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—JAG1—pancreatic cancer	0.000219	0.000248	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOTCH3—pancreatic cancer	0.000219	0.000247	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—CXCL8—pancreatic cancer	0.000213	0.00024	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TERT—pancreatic cancer	0.000212	0.000239	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CNR1—pancreatic cancer	0.00021	0.000237	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CNR1—pancreatic cancer	0.000209	0.000236	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CNR1—pancreatic cancer	0.000207	0.000234	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000203	0.00023	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000203	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TERT—pancreatic cancer	0.000203	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—GCG—pancreatic cancer	0.000202	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HIF1A—pancreatic cancer	0.000202	0.000229	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TSC2—pancreatic cancer	0.000202	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—GCG—pancreatic cancer	0.000202	0.000228	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000201	0.000227	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—GCG—pancreatic cancer	0.0002	0.000226	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—APOE—pancreatic cancer	0.000197	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000197	0.000223	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000196	0.000222	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—TYMS—pancreatic cancer	0.000195	0.000221	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000194	0.00022	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HIF1A—pancreatic cancer	0.000194	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KDR—pancreatic cancer	0.000193	0.000219	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TSC2—pancreatic cancer	0.000193	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000193	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AGTR1—pancreatic cancer	0.000193	0.000218	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AGTR1—pancreatic cancer	0.000191	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STK11—pancreatic cancer	0.00019	0.000215	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STK11—pancreatic cancer	0.00019	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—APOE—pancreatic cancer	0.000189	0.000214	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STK11—pancreatic cancer	0.000188	0.000212	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KDR—pancreatic cancer	0.000185	0.000209	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NFKBIA—pancreatic cancer	0.000184	0.000208	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NOTCH1—pancreatic cancer	0.000182	0.000206	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000179	0.000202	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000178	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CG—pancreatic cancer	0.000178	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—NRAS—pancreatic cancer	0.000178	0.000201	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000177	0.0002	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NFKBIA—pancreatic cancer	0.000176	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGF—pancreatic cancer	0.000176	0.000199	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NOTCH1—pancreatic cancer	0.000175	0.000197	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000172	0.000194	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000171	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CG—pancreatic cancer	0.000171	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—NRAS—pancreatic cancer	0.000171	0.000193	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000169	0.000192	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGF—pancreatic cancer	0.000169	0.000191	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.000167	0.000188	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SMAD4—pancreatic cancer	0.000166	0.000188	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000165	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SMAD4—pancreatic cancer	0.000165	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000164	0.000186	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000163	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HES1—pancreatic cancer	0.000163	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—EGFR—pancreatic cancer	0.000162	0.000184	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HES1—pancreatic cancer	0.000162	0.000183	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HES1—pancreatic cancer	0.000161	0.000182	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—APOE—pancreatic cancer	0.000159	0.000179	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CD—pancreatic cancer	0.000157	0.000177	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000156	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—EGFR—pancreatic cancer	0.000155	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000155	0.000176	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000155	0.000175	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000154	0.000174	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—KRAS—pancreatic cancer	0.000153	0.000173	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CD—pancreatic cancer	0.00015	0.00017	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—CXCL8—pancreatic cancer	0.00015	0.000169	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—CXCL8—pancreatic cancer	0.000149	0.000169	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000149	0.000168	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—CXCL8—pancreatic cancer	0.000148	0.000167	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—KRAS—pancreatic cancer	0.000147	0.000166	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CG—pancreatic cancer	0.000143	0.000162	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TERT—pancreatic cancer	0.000143	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TERT—pancreatic cancer	0.000142	0.000161	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000141	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TERT—pancreatic cancer	0.000141	0.000159	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PPARG—pancreatic cancer	0.000138	0.000156	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CB—pancreatic cancer	0.000137	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HIF1A—pancreatic cancer	0.000136	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TSC2—pancreatic cancer	0.000136	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HIF1A—pancreatic cancer	0.000136	0.000154	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TSC2—pancreatic cancer	0.000136	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000135	0.000153	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HIF1A—pancreatic cancer	0.000135	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TSC2—pancreatic cancer	0.000134	0.000152	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—APOE—pancreatic cancer	0.000133	0.000151	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—APOE—pancreatic cancer	0.000133	0.00015	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—APOE—pancreatic cancer	0.000131	0.000149	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CXCL8—pancreatic cancer	0.000131	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CB—pancreatic cancer	0.000131	0.000148	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KDR—pancreatic cancer	0.00013	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—HRAS—pancreatic cancer	0.00013	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KDR—pancreatic cancer	0.00013	0.000147	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KDR—pancreatic cancer	0.000129	0.000146	CbGpPWpGaD
Trihexyphenidyl—CHRM4—GPCR downstream signaling—AKT1—pancreatic cancer	0.000127	0.000143	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CD—pancreatic cancer	0.000126	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CXCL8—pancreatic cancer	0.000126	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CASP3—pancreatic cancer	0.000126	0.000142	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—HRAS—pancreatic cancer	0.000125	0.000141	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000124	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NFKBIA—pancreatic cancer	0.000124	0.00014	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000123	0.000139	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NOTCH1—pancreatic cancer	0.000122	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NFKBIA—pancreatic cancer	0.000122	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CCND1—pancreatic cancer	0.000122	0.000138	CbGpPWpGaD
Trihexyphenidyl—CHRM5—GPCR downstream signaling—AKT1—pancreatic cancer	0.000121	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NOTCH1—pancreatic cancer	0.000121	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—CTNNB1—pancreatic cancer	0.000121	0.000137	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CASP3—pancreatic cancer	0.00012	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CG—pancreatic cancer	0.00012	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—NRAS—pancreatic cancer	0.00012	0.000136	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CG—pancreatic cancer	0.00012	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—NRAS—pancreatic cancer	0.00012	0.000135	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGF—pancreatic cancer	0.000119	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MMP9—pancreatic cancer	0.000119	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CG—pancreatic cancer	0.000119	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—NRAS—pancreatic cancer	0.000119	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGF—pancreatic cancer	0.000118	0.000134	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PTEN—pancreatic cancer	0.000118	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGF—pancreatic cancer	0.000117	0.000133	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CCND1—pancreatic cancer	0.000117	0.000132	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—CTNNB1—pancreatic cancer	0.000116	0.000131	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling by GPCR—AKT1—pancreatic cancer	0.000115	0.00013	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MMP9—pancreatic cancer	0.000114	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PTEN—pancreatic cancer	0.000113	0.000128	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling by GPCR—AKT1—pancreatic cancer	0.00011	0.000125	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CB—pancreatic cancer	0.00011	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—EGFR—pancreatic cancer	0.000109	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—SRC—pancreatic cancer	0.000109	0.000124	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—EGFR—pancreatic cancer	0.000109	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTGS2—pancreatic cancer	0.000109	0.000123	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—EGFR—pancreatic cancer	0.000108	0.000122	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—VEGFA—pancreatic cancer	0.000107	0.00012	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000106	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—STAT3—pancreatic cancer	0.000106	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—NRAS—pancreatic cancer	0.000105	0.000119	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—SRC—pancreatic cancer	0.000105	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000105	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CD—pancreatic cancer	0.000104	0.000118	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—KRAS—pancreatic cancer	0.000103	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000103	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—KRAS—pancreatic cancer	0.000103	0.000117	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—KRAS—pancreatic cancer	0.000102	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—VEGFA—pancreatic cancer	0.000102	0.000115	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—STAT3—pancreatic cancer	0.000101	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—NRAS—pancreatic cancer	0.000101	0.000114	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—MYC—pancreatic cancer	9.81e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TGFB1—pancreatic cancer	9.78e-05	0.000111	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—EGFR—pancreatic cancer	9.59e-05	0.000108	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.5e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PTEN—pancreatic cancer	9.49e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—PIK3CA—pancreatic cancer	9.47e-05	0.000107	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—MYC—pancreatic cancer	9.39e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.38e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TGFB1—pancreatic cancer	9.37e-05	0.000106	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CB—pancreatic cancer	9.21e-05	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—EGFR—pancreatic cancer	9.19e-05	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CB—pancreatic cancer	9.18e-05	0.000104	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CB—pancreatic cancer	9.09e-05	0.000103	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—KRAS—pancreatic cancer	9.06e-05	0.000102	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CXCL8—pancreatic cancer	8.85e-05	0.0001	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CXCL8—pancreatic cancer	8.82e-05	9.97e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—HRAS—pancreatic cancer	8.79e-05	9.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	8.76e-05	9.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	8.74e-05	9.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	8.68e-05	9.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	8.68e-05	9.81e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	8.55e-05	9.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	8.52e-05	9.63e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	8.47e-05	9.57e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	8.44e-05	9.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	8.44e-05	9.54e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	8.36e-05	9.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	8.33e-05	9.41e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	8.24e-05	9.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	8.22e-05	9.29e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	8.16e-05	9.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	8.14e-05	9.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	8.14e-05	9.2e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	8.06e-05	9.11e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—TP53—pancreatic cancer	8.05e-05	9.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	8e-05	9.05e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	7.98e-05	9.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	7.97e-05	9.01e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	7.96e-05	8.99e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	7.93e-05	8.96e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	7.9e-05	8.93e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	7.85e-05	8.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	7.76e-05	8.77e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	7.74e-05	8.75e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—TP53—pancreatic cancer	7.71e-05	8.72e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	7.7e-05	8.71e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	7.66e-05	8.66e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—SRC—pancreatic cancer	7.38e-05	8.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	7.38e-05	8.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—SRC—pancreatic cancer	7.36e-05	8.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—SRC—pancreatic cancer	7.28e-05	8.23e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	7.19e-05	8.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	7.16e-05	8.1e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	7.12e-05	8.04e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	7.1e-05	8.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	7.09e-05	8.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	7.09e-05	8.02e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	7.08e-05	8e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	7.02e-05	7.94e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	7.01e-05	7.92e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	6.8e-05	7.69e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—PIK3CA—pancreatic cancer	6.69e-05	7.56e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—MYC—pancreatic cancer	6.61e-05	7.47e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	6.6e-05	7.46e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—MYC—pancreatic cancer	6.59e-05	7.45e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	6.58e-05	7.43e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—MYC—pancreatic cancer	6.53e-05	7.38e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	6.51e-05	7.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	6.51e-05	7.36e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	6.47e-05	7.31e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	6.45e-05	7.29e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	6.38e-05	7.22e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	6.11e-05	6.91e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	6.09e-05	6.88e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	6.03e-05	6.82e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	5.61e-05	6.34e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	5.6e-05	6.32e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	5.54e-05	6.26e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Metabolism—AKT1—pancreatic cancer	5.47e-05	6.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—TP53—pancreatic cancer	5.43e-05	6.14e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—TP53—pancreatic cancer	5.41e-05	6.12e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—TP53—pancreatic cancer	5.36e-05	6.06e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	5.19e-05	5.87e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	5.18e-05	5.85e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	5.13e-05	5.79e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	4.59e-05	5.18e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	4.57e-05	5.17e-05	CbGpPWpGaD
Trihexyphenidyl—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	4.53e-05	5.12e-05	CbGpPWpGaD
